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Signal amplifications are vital for chromatin function, yet they also bear the risk of transforming into
unrestrained, self-escalating, and potentially harmful responses. Examples of inbuilt limitations are
emerging, revealing how chromatin transactions are confined within physiological boundaries.Diverse biochemical activities constantly occur at eukaryotic
chromosomes, and most of these processes are essential for
normal function of cells and tissues. Yet although activities
involved in DNA replication, transcription, and DNA repair are vi-
tal for cell proliferation, for protein homeostasis, and to prevent
accumulation of mutations, they also pose a potential threat by
interfering with the structure of DNA and its protein scaffold.
Thus, most chromatin transactions can be seen as a double-
edged sword. On the one hand, they flexibly meet cellular needs
and dynamically respond to external cues. On the other, by virtue
of their ability to modify nucleic acids and associated proteins,
they may destabilize the (epi)genome, especially if allowed to
function at the wrong times and/or beyond the proper nuclear
compartments. Whereas the pathological consequences of
reduced chromatin transactions are widely recognized, recent
work has begun to reveal that excessive enzymatic activities
may be equally harmful.
The need for tight surveillance against excessive signaling
becomes apparent when considering that some chromatin
transactions must be launched very rapidly, for instance in the
case of DNA damage repair, and therefore crucially rely on initial
amplification mechanisms to overcome physiological barriers
(Altmeyer and Lukas, 2013). Such amplification reactions must
be closely monitored and efficiently controlled to avoid unre-
strained signal propagation and its potentially detrimental con-
sequences. For example, uncontrolled spatial spreading of chro-
matin modifications could perturb gene expression patterns and
alter repair pathway choice, and prolonged temporal DNA dam-
age signaling could lead to irreversible cell-cycle arrest or poten-
tially toxic DNA damage checkpoint adaptation. Failure to care-
fully monitor and limit DNA and chromatin transactions could
thus cause uncontrolled proliferation and cellular transformation
and have a profound impact on organismal development and
physiology, with important implications for human disease.
The purpose of this Minireview is to highlight the emerging
notion that, in order to spatially and temporally confine DNA
and chromatin transactions, which typically involve posttransla-
tional modifications of key enzymatic components, cells cannot
purely rely on the reversion of initiated modifications by demodi-
fication reactions. Instead, recent work indicates that additional
layers of control have evolved to restrict DNA and chromatintransactions, even at the cost that these transactions do not
always operate with the highest possible efficiency.
Limiting Chromatin Modifications after DNA Damage
A sophisticated signaling network is activated in response to
DNA breakage to rapidly locate the lesion and trigger signaling
pathways that initiate repair and coordinate it with vital cellular
functions. An important aspect of these early signaling events
is the posttranslational modification of chromatin by enzymes
that are specifically recruited to and activated at damaged sites.
The DNA damage response uses multiple feed-forward loops to
overcome initial thresholds and efficiently kick-start DNA dam-
age signaling (Altmeyer and Lukas, 2013; Lukas et al., 2011).
Chromatin modifications then spread away from the break site
to generate a specialized chromatin domain with a DNA-dam-
age-specific make-up comprising a range of histone modifica-
tions, including nonproteolytic ubiquitin conjugates that are
required to recruit genome caretakers to the damage sites.
Although the timely generation of this domain is needed to
assemble downstream components of the DNA repair machin-
ery and is thus beneficial for repair, the spreading of chromatin
modifications away from damaged sites may overly affect un-
damaged parts of the genome. This can be best illustrated by
RNF168, the key catalytic workhorse that generates ubiquitin
conjugates at damaged chromosomes: RNF168 has inbuilt
auto-amplification properties because it combines ubiquitin-
binding modules with ubiquitin-ligase activity (Gudjonsson
et al., 2012; Panier et al., 2012). Thus, RNF168 can bind its
own reaction products and thereby reinforce the spreading of
chromatin ubiquitylation. How then do cells limit the spreading
of RNF168-dependent chromatin ubiquitylation? One way, as
elegant as simple, seems to be to keep the number of RNF168
molecules in cells low so that steady-state enzyme levels sup-
port only limited spreading. Indeed, two ubiquitin E3 ligases,
TRIP12 and UBR5, co-operate to control RNF168 levels, and
deregulation of these enzymes causes accumulation of
RNF168 to supraphysiological levels and as much as four-fold-
enhanced spreading of ubiquitin conjugates from the sites of
damage, resulting in excessive gene silencing in these regions,
sometimes even of whole chromosomes (Figure 1A). Strikingly,
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Figure 1. Mechanisms Guarding against Unrestrained Chromatin Transactions
(A) Chromatin ubiquitylation in response to DNA damage. (B) Histone phosphorylation in response to DNA damage. (C) Histone methylation and acetylation for
transcriptional activation. (D) RNA polymerase II occupancy and transcription of transposable elements and flanking genes. (E) DNA end resection in mammalian
cells. (F) Cell-cycle checkpoint duration in response to DNA breaks. DUBs, deubiquitylating enzymes; Ub, ubiquitin; PPs, protein phosphatases; TE, transposable
elements.enhanced DNA repair dynamics, in particular by increasing the
efficiency of repair via the nonhomologous end-joining (NHEJ)
pathway and even promoted short-term survival of ionizing radi-
ation (Gudjonsson et al., 2012). These results revealed the sur-
prising fact that chromatin does not possess specific insulators
against DNA damage-induced histone ubiquitylation. Moreover,
the DNA repair machinery normally operates with suboptimal ef-
ficiency, a limitation that likely reflects evolutionary pressure to
minimize collateral damage, such as adverse effects on gene
expression in undamaged areas of the genome or accumulation
of mutations that can occur more readily when fast but error-
prone repair pathways such as NHEJ are used.
Likely underscoring the need to limit DNA-damage-associated
histone ubiquitylation to the minimum level that supports DNA
repair, nature introduced yet another layer of control exemplified
by the RNF168 paralog RNF169 (Chen et al., 2012; Panier et al.,
2012; Poulsen et al., 2012). Through its ubiquitin-interacting
motif, RNF169 can directly compete with RNF168 for the binding
of DNA-damage-induced ubiquitin chains, thereby antagonizing1432 Cell 153, June 20, 2013 ª2013 Elsevier Inc.the RNF168-mediated amplification reaction. Thus, while
RNF168 steady-state protein levels set a physiological limit to
prevent excessive chromatin ubiquitylation, the competition for
ubiquitin binding by RNF169 further reinforces a barrier against
the spreading of this modification. Together with the activities
of deubiquitylating enzymes (Lukas et al., 2011), these mecha-
nisms cooperate to ensure that chromatin ubiquitylation remains
within its physiological boundaries (Figure 1A).
These recent findings shed light on themechanisms employed
by cells to oversee and control chromatin ubiquitylation in
response to genotoxic stress. But how is the spreading of other
chromatin modifications limited? In the case of histone phos-
phorylation, which is the most upstream response elicited by
DNA damage and can spread over several hundred kb in cis
and even affect chromosomes in trans, the chromatin structure
itself seems to limit uncontrolled spreading (Kim et al., 2007;
Murga et al., 2007). For instance, cells with half the normal
amount of the linker histone H1, hence a less compact and
more accessible chromatin composition, show increased
chromatin phosphorylation, enhanced cell-cycle checkpoint
activation, and are hyperresistant to DNA damage in survival as-
says (Murga et al., 2007). This striking example of excessive
signaling due to reduced levels of a general chromatin
compactor suggests that higher-order chromatin superstructure
poses a natural barrier to excessive signaling by the apical DNA
double-strand-break-induced protein kinases and further rein-
forces the notion that the evolutionary benefit of introducing a
chromatin compactor outweighs the maximum efficiency of
DNA repair-associated signaling (Figure 1B).
Limiting Modifications to Regulate Transcription
Limitations to chromatin transactions are not only important to
confine modifications induced by genotoxic stress, but also
occur in the context of epigenetic gene regulation in the absence
of DNA damage. For instance, active chromatin marks that are
normally confined to gene promoter regions can spread when
surveillance mechanisms are perturbed. Exciting mechanistic
insight into such regulation revealed that, in Drosophila, the tran-
scriptional regulator UpSET, a SET and PHD-domain-containing
protein with similarity to mammalian MLL5 and SETD5, restricts
histone acetylation and chromatin accessibility to promoter re-
gions (Rincon-Arano et al., 2012). Strikingly, in the absence of
UpSET, active chromatin marks spread over at least 2.5 kb
into silent neighboring genes and into flanking repetitive
elements, enhancing activation of cryptic promoters and trans-
posons (Figure 1C). There is a remarkable conceptual similarity
between restraining the DNA-damage-induced histone ubiquity-
lation by RNF168 (Gudjonsson et al., 2012) and the transcription-
coupled histone methylation by the MLL complex (Demers et al.,
2007; Rincon-Arano et al., 2012): in both cases, an active mech-
anism limits spreading of an epigenetic writer with an intrinsic
propensity to self-propagate along the chromatin fiber.
Similar to active chromatin marks, heterochromatin spreading
can also exceed physiological limits when boundary elements
are deleted, and it was suggested that the finite spreading
distance in chromatin can be dictated by a dose-limiting compo-
nent of the heterochromatin assembly machinery (Allis and Muir,
2011). For the transcriptional silencing of transposons in
Drosophila, for instance, the piRNA pathway components Piwi-
RISC and Maelstrom seem to determine the extent of hetero-
chromatin spreading and transcriptional repression (Sienski
et al., 2012). Loss of Piwi or Maelstrom caused directional dere-
pression and pronounced ‘‘bleeding’’ of RNA polymerase II into
flanking regions over15 kb, resulting in severely elevated levels
of gene expression, often increased by more than 10-fold
(Figure 1D). These new insights into piRNA-mediated silencing
of transposons once again illustrate the need to suppress
spreading of chromatin transactions into nearby genomic re-
gions.
Limiting DNA End Resection and Checkpoint Signaling
Though unrestrained spreading of chromatin marks poses a
severe threat to physiological gene expression patterns and
chromatin homeostasis, unrestrained transactions directly at
the level of DNA, such as excessive or untimely nucleolytic
digestion of DNA ends, is even more dangerous. Mechanisms
have thus evolved to protect exposed DNA ends from unsched-uled resection, a function that, in mammalian cells, was recently
shown to depend on the telomere-associated protein RIF1
(Chapman et al., 2013; Di Virgilio et al., 2013; Escribano-Dı´az
et al., 2013; Zimmermann et al., 2013). RIF1 interacts with the
phosphorylated form of the genome caretaker 53BP1 and allows
DNA repair via NHEJ by suppressing unscheduled homology-
directed repair (HDR) (Figure 1E). The protective function of
53BP1 and RIF1 has important implications for immunoglobulin
class switch recombination, dysfunctional telomere fusion, and
counteracting genome instability, thus underlining the phys-
iological relevance of cellular mechanisms that prevent unre-
strained chromatin and DNA transactions.
DNA end resection not only determines repair pathway choice,
but also generates a structural platform for signaling pathways
that connect the sites of damagewith the entire nucleus and acti-
vate cell-cycle checkpoints. In contrast to spreading of chro-
matin modifications induced by genotoxic stress, local confine-
ments are usually dispensable or even unfavorable for cell-cycle
checkpoint activation. Yet signal spreading to cell-cycle effec-
tors must be held in check, and temporal limitations must be
imposed to avoid ‘‘collateral damage’’ manifested, for instance,
by permanent cell-cycle arrest or even cellular transformation, as
recently revealed by the ‘‘super-Chk1’’ mouse, engineered to
express an extra allele of the master signaling kinase activated
after DNA damage (Lo´pez-Contreras et al., 2012). Despite their
importance, relatively little is known about the mechanisms
that limit the magnitude and duration of checkpoint signaling.
One intriguing mechanism by which DNA damage checkpoint
signaling self-monitors was unveiled recently in yeast. Here,
the DNA repair scaffolding proteins Slx4 and Rtt107 modulate
the activity of the checkpoint kinase Rad53 by a competition-
based mechanism (Ohouo et al., 2013). The anti-checkpoint in-
volves detection of phosphorylated H2A by Rtt107, which brings
along Slx4 to stabilize yet another phospho-dependent interac-
tion between Slx4 and the replication factor Dpb11. Because
Dpb11 also binds Rad9 to promote Rad9-dependent Rad53
activation, its interaction with Slx4 provides a safe-
guard mechanism to dampen checkpoint adaptor-mediated
phosphosignaling, abbreviated DAMP (Ohouo et al., 2013). The
authors also note that, by uncoupling upstream Mec1-depen-
dent signaling from downstream Rad53 activation, DAMP could
locally boost beneficial signaling to specific repair enzymes
without persistent cell-cycle arrest. Though further studies are
needed to determine exactly under which conditions and to
what extent cells would normally abolish cell-cycle arrest in the
presence of ongoing DNA repair signaling and potentially unfin-
ished repair, the work byOhouo et al. shows how two scaffolding
proteins (Slx4 and Rtt107) counteract excessive checkpoint
signaling (by Rad53) through physical interactions with positive
regulators of a checkpoint kinase adaptor (Rad9) (Figure 1F).
Concluding Remarks and Future Challenges
Chromatin transactions confront cells with an exquisite chal-
lenge: cells need to elicit fast and strong responses to overcome
physiological barriers and quickly adapt to changing conditions,
yet they must keep these reactions in check to avoid excessive
chromatin modification and signaling (Figure 2). Tipping the
balance to either insufficient or to unrestrained reactions canCell 153, June 20, 2013 ª2013 Elsevier Inc. 1433
Figure 2. Mechanisms to Reinforce and
Restrain Chromatin Transactions Balance
Benefit and Risk
As in Figure 1, initiating and reinforcing activities
are highlighted in blue, and limiting activities are
marked in purple.have pathological consequences, and cells have evolved to pre-
cisely balance the benefits and risks of these reactions.
Research in the field has uncovered important mechanisms
that initiate and reinforce chromatin transactions. How cells
counterbalance these transactions, however, is an area that
we are only beginning to capture. The first intriguing examples
of inbuilt restrictions have recently emerged, and many more
are bound to broaden their spectrum beyond the chromatin
compartment. A mechanism restraining feed-forward RNAi
amplification is among the most intriguing recent examples of
this development (Pak et al., 2012). Clearly, and more often
than we have anticipated, it becomes apparent that the reversal
of enzymatic activities by counteracting enzymes is not sufficient
to restrain chromatin transactions and the associated signaling
and that evolution has equipped cells with a fascinating spec-
trum of dedicated molecular guardians that restrict excessive
chromatin responses at the cost of their efficiency but with the
long-term benefit of minimizing collateral damage in the form
of unwanted alterations of the (epi)genetic code. It could be
highly informative to investigate such evolutionary compromises
and their long-term effects, for instance, by introducing extra
alleles of rate-limiting components in animal models and
following their genomic ‘‘fitness’’ over multiple generations.
Moreover, with the first examples of inbuilt restrictions at hand,
we should now obtain more precise quantitative information
about the extent of chromatin transactions and the relative con-
tributions of intrinsic barriers to their excessive spreading, e.g.,
by integrating insights from in situ cell imaging with genomics
data and by combining such experimental evidence with mathe-
matical modeling. Regarding the latter, exciting inspiration has
been provided by models describing signaling networks that
drive unidirectional cell-cycle progression (Yang and Ferrell,
2013), but we urgently need more systematic efforts in this
area. Only then will we be able to generate a holistic picture of
the temporal and spatial limitations that guard our genome
from collateral damage—safeguard mechanisms that we are
only beginning to understand.ACKNOWLEDGMENTS
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